Clinical Report: Exploring Acupuncture as a Host-Directed Therapy for Neuroinfectious Diseases
Overview
This report examines the potential of acupuncture as a host-directed therapy for neuroinfectious diseases, highlighting its ability to modulate immune responses and promote recovery. While evidence is primarily derived from non-infectious models, acupuncture shows promise in addressing neuroinflammation and related neurological outcomes.
Background
Neuroinfectious diseases pose significant challenges to global health, often leading to severe morbidity and mortality. Current treatments, primarily antimicrobial therapies, frequently result in suboptimal clinical outcomes due to the dual nature of host immune responses, which can contribute to neuroinflammation and neuronal injury. This has led to increased interest in host-directed therapies that aim to recalibrate immune responses rather than solely targeting pathogens.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
Acupuncture may modulate inflammatory signaling and microglial activation.
It has potential effects on blood-brain barrier integrity and oxidative stress.
Evidence suggests acupuncture improves functional recovery in stroke patients, paralleling mechanisms in neuroinfectious diseases.
Similar benefits have been observed in long COVID, indicating neuroimmune modulation as a possible mechanism.
Acupuncture acts through defined neuroimmune pathways, potentially engaging central autonomic circuits.
Clinical Implications
Acupuncture may serve as a non-pharmacological adjunctive strategy in managing neuroinfectious diseases by modulating host immune responses. Further systematic investigation is warranted to establish its therapeutic potential in this context.
Conclusion
While direct evidence of acupuncture's efficacy in neuroinfectious diseases remains limited, its biological plausibility as a host-directed therapy warrants further exploration.
